EFFECTS OF CONSTANT INFUSION WITH INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) TO IMMATURE FEMALE RATS ON BODY-WEIGHT GAIN, TISSUE-GROWTH, AND SEXUAL FUNCTION - EVIDENCE THAT SUCH TREATMENT DOES NOT AFFECT SEXUAL-MATURATION OR FERTILITY
Nm. Gruaz et al., EFFECTS OF CONSTANT INFUSION WITH INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) TO IMMATURE FEMALE RATS ON BODY-WEIGHT GAIN, TISSUE-GROWTH, AND SEXUAL FUNCTION - EVIDENCE THAT SUCH TREATMENT DOES NOT AFFECT SEXUAL-MATURATION OR FERTILITY, Endocrine, 6(1), 1997, pp. 11-19
Plasma levels for insulin-like growth factor-1 (IGF-I) steadily increa
se in female rats between 20 and 40 d of life, and this increase is in
timately related to the well-known growth spurt occurring at this age.
Since specific actions of IGF-I related to sexual function have been
described at the ovarian and hypothalamic levels, an endocrine role of
rising circulating IGF-I levels during sexual maturation cannot be ex
cluded. Therefore, the impact of adult-type plasma IGF-I levels during
the juvenile age, on body weight (BW) gain, growth of several organs,
sexual development, and fertility has been evaluated. Female Sprague-
Dawley rats were infused with rhIGF-I (2 and 4 mu g/g BW/d, using Alze
t minipumps), between 20 and 41 d of life. When infusing 2 mu g/g BW/d
, plasma levels for IGF-I were increased 1.5- to 2-fold over controls
at all ages studied. They were further increased with the higher dosag
e, but only after 35 d of age. Plasma levels for insulin-like growth f
actor binding protein (IGFBP)-1 to -3 were clearly increased. BW gain
was significantly increased, but only with the higher dosage. Tail len
gth was never modified. In contrast, a growth acceleration for spleen,
kidneys, adrenals, and ovaries was observed with both dosages. The ov
arian weight of treated animals represented approx 140% of control ani
mals with the 4 mu g/g BW/d dosage. Histology of the enlarged ovaries
did not reveal any abnormalities. No meaningful modification of the ti
ming of vaginal opening was observed, and fertility was not compromise
d by previous rhIGF-I infusion during the 20-41 d age period. In summa
ry, early exposure to increased (adult-like) plasma IGF-I levels did n
ot modify BW gain or tail length, but affected the development of sple
en, kidneys, adrenals, and ovaries. Exposure to supraphysiological pla
sma IGF-I levels (>1200 ng/mL), accelerated BW gain and increased the
weight of all organs studied. No signs of precocious sexual maturation
were seen and fertility was normal. In conclusion, prematurely increa
sed plasma IGF-I levels affected somatotropic parameters, but not the
onset of sexual function.